The brainstem-derived neuropeptide S (NPS) has a multidirectional regulatory activity, especially as a potent anxiolytic factor. Accumulating data suggests that neuroleptics affect peptidergic signaling in various brain structures. However, there is no information regarding the influence of haloperidol on NPS and NPS receptor (NPSR) expression. We assessed NPS and NPSR mRNA levels in brains of rats treated with haloperidol using quantitative Real- 
Introduction
Neuropeptide S (NPS) is a selective 20-amino acid ligand for the NPS receptor (NPSR), a Gs and Gq -coupled receptor formerly identified as orphan receptor GPR 154 (1) .
NPS is an endogenous modulator of a wide spectrum of physiological activities in the brain. It exerts anxiolytic effects, stabilizes arousal state, regulates food intake as well as plays a role in the pathomechanism of fear modulation and addiction (2) (3) (4) (5) (6) (7) (8) . In the rat brain, expression of NPS is shown almost exclusively within the locus coeruleus, principal trigeminal nucleus and lateral parabrachial nucleus, whereas in mouse NPS expression in the Kölliker-Fuse nucleus has also been reported (9) . In contrast to the specific expression of NPS, NPSR mRNA is abundant within the brain and has been detected in the olfactory bulb, piriform cortex, amygdala, hypothalamus, thalamus and brainstem (10) . Receptor stimulation leads both to a release of Ca 2+ reserves to the neuroplasm and to an increase of cAMP levels (11, 1) . From a neuropsychiatric viewpoint, the most important role of NPS seems to be its activity at the level of neuronal pathways related to the neurobiology of fear (12) . A number of behavioral tests prove that central or even intranasal NPS administration has a strong anxiolytic effect in rats, which may be related to an increase of dopamine release in the medial prefrontal cortex (13, 14) . The stimulatory effect of NPS on dopaminergic signaling suggests that this neuropeptide might increase dopamine synthesis and/or its turnover within the synaptic cleft (14) . Moreover, NPS application to organotypic hippocampal slices activated synaptic plasticity in CA1 and CA3 areas, whereas targeted NPS microinjection directly to the ventral CA1 was enough to reduce fear related behaviour in mice (15) . Furthermore, under in vitro conditions NPS, acting through its receptor, weakens the neural activity stream from the dentate gyrus to the CA1 area (15) . NPS peptide administration into the mouse amygdala results in conditioned fear elimination, but it has no effect before the conditioning process 4 (16) . Recent experiments on healthy individuals also suggest, that NPSR gene T-alleles could be connected with fear, excessive stress reaction and increased HPA axis stimulation (5).
Moreover, NPSR1 gene variation affects the glutamate/glutamine (Glx) levels in the rat cingulate cortex during induced panic attacks (17) . Studies by Zhang et al. (18) prove that NPS expression in the locus coeruleus and a decrease of NPSR internalization level in the limbic system coexist with chronic pain and anxiety (24) . On the other hand, NPS can stimulate inhibitory GABAergic transmission in the rat medial amygdala, reducing fear related responses (16) . The NPS signaling may be also involved in the regulation of HPA axis acting as a part of negative feedback loop in the response to various stress stimuli (4).
Another clinically intriguing report has associated NPSR polymorphisms with neuropsychiatric disorders including schizophrenia (19) . Noteworthy, anxiety is considered as an important and relatively frequent symptom of schizophrenia, which is significantly connected with an elevated risk of severe consequences including suicidal behaviour (20) .
Post-traumatic stress disorder (PTSD) and obsessive compulsive disorder (OCD) are present in 38.3% of patients suffering from schizophrenia (21) . Interestingly, some recent findings suggest a role of the NPS signaling in the regulation of motor functions at the level of basal ganglia (22, 23) .
Haloperidol, a classical but still widely administered D 2 receptor antagonist effectively reduces the psychosis suggesting impaired dopaminergic signaling as a key mechanism of positive schizophrenia symptoms (24) . Noteworthy, haloperidol is a non-specific neuroleptic with affinity to numerous receptors, including dopamine D2, serotonin 5-HT2, -adrenergic and -opioid receptors (25) (26) (27) . Haloperidol shows either potentially beneficial anxiolytic and sedative properties or a wide spectrum of unfavorable side effects including tardive dyskinesia, neuroleptic malignant syndrome, akathisia and QT-interval prolongation (28) (29) (30) .
Nevertheless, the neurochemical mechanism of anxiolytic and dyskinetic actions of 5 neuroleptics, both classical and atypical, is so far poorly understood. Some reports show that atypical antipsychotics, but not haloperidol can upregulate the level of steroid GABA A receptor stimulators in the rat brain (31) . In turn, the blockage of serotonin 5-HT2 receptors with haloperidol may be responsible for its anxiolytic effect (32) . Hypothetically, the peptidergic signaling systems may play a significant role in the central regulation of anxietyrelated events.
Aims of the Study
Accumulating but still limited findings suggest that neuroleptics may affect peptidergic regulatory pathways in various brain structures. For example, both chlorpromazine and clozapine affect corticotropin-releasing hormone (CRH) expression probably via activation of the PI3K/Akt signalling cascade, however PKC-related pathway may be also involved (33) .
Haloperidol stimulates CRH mRNA expression and also increases the gonadotropin-releasing hormone (GnRH) secretion in the rat hypothalamus (34) . In turn, both quetiapine and olanzapine are able to inhibit the release of CRH from isolated rat hypothalami and hippocampi (35) . Haloperidol upregulates neurotensin levels in the rat striatum, hippocampus and the frontal cortex, but risperidone decreases the peptide expression (36). Conversely, long-term treatment with haloperidol decreases NPY mRNA levels in the rat amygdala and hippocampus, while olanzapine and clozapine show the same effect in the striatum, nucleus accumbens and anterior cingulated cortex (37) . Long-term treatment with risperidone also downregulates the NPY mRNA expression in the rat hypothalamus (38) . In contrast, a stimulatory effect of subchronically administered olanzapine on NPY expression is also 6 suggested (39). Olanzapine increases calcitonin gene-related peptide (CGRP) immunoreactivity in the rat brain (40) .
Despite these ongoing studies, almost no data exists regarding the interaction of neuroleptics with brain NPS signalling. We therefore examined the effect of administration of haloperidol, a classical butyrophenone type antipsychotic drug, on NPS and NPSR expression in the rat brain and showed a robust significant increase in brainstem NPS mRNA expression as a result of chronic drug administration.
Materials and methods

Animals
The experiments were performed on adult male Sprague-Dawley rats (2-3 months old, 180-210 g). We injected two groups of animals (n=4) with either control vehicle (saline) or haloperidol (2 mg/kg/day) every day for 4 weeks (28 injections per rat). All procedures were conducted in a manner consistent with NIH Guidelines for Care and Use of Laboratory Animals and approved by the Local Bioethical Committee at the Medical University of Silesia (agreement no. 36/2012).
Material collection and reverse transcription 24 hours after the last drug administration, animals were anaesthetized with isoflurane.
Then, the brains were quickly removed and we performed microsurgical excision of samples from hypothalamus, hippocampus, striatum and brainstem. After that, all samples were homogenized with an ultrasound homogenizer (Heildolph DIAX 900, Germany) in 1 ml of 
Statistics
Statistical analysis was done with Statistica (Systat Software). We presented data (on graphs) as mean ± SEM. Mean differences between groups of animals were analyzed using non-parametric Kruskall-Wallis test. Differences were considered statistically significant at p ≤ 0,05.
8
Results
In the current study, rats treated chronically with haloperidol manifested strongly increased relative NPS mRNA expression in the brainstem; 128,75 ± 6,48 versus control:
1,08 ± 0,33 (p = 0,000246). Although, there is an unexpectedly massive (about 120-fold)
increase of NPS mRNA level in this region we excluded the effect of haloperidol on GAPDH expression, as mean Cq values for this gene are very similar for control animals (15,65) and for haloperidol treated animals (15, 48) . We have also found a trend for decreased NPS mRNA level in the hypothalamus: 13,79 ± 0,36 versus control: 15,59 ± 4,09, nevertheless this change was not statistically significant ( (46) whereas Stockton and Rasmussen (47) showed that chronic exposition to olanzapine results in a decreased number of active neurons in A10, but not in A9
area.
Interestingly, after long-term treatment with haloperidol, the NPSR mRNA levels were downregulated both in the hippocampus and striatum. This result is consistent with our recent finding that NPSR mRNA levels in the same structures were decreased after chronical chlorpromazine and olanzapine administration. Additionally, both short and long-term exposition to chlorpromazine decreased the NPS mRNA level in the hypothalamus (41).
Presented phenomena are rather difficult to interpret without specific analysis of potential interactions between NPSR mode of action and dopaminergic signaling. Possibly, haloperidol may modulate the NPS-related synaptic plasticity in the hippocampus mediating any kinds of fear responses (15) . Probably, the high elevation of NPS mRNA level in brainstem neurons may suggest an increased neuropeptide synthesis and release to the hippocampal formation and striatum. Thus, it should be taken into consideration that a decrease in NPSR mRNA expression could be a compensatory response to increased NPS concentration in these structures. In contrast, the NPSR mRNA level in brainstem was distinctly elevated after chronical haloperidol administration. Theoretically, this neuroleptic could increase the sensitivity and/or activity of NPS signaling in the brainstem and in consequence facilitate 11 anxiolytic mechanisms. Importantly, the brainstem contains a distinct population of aminergic NPSR-expressing neurons (10) that play numerous central roles such as modulation of cortical glutamatergic transmission and maintaining the arousal state. We therefore can hypothesize that haloperidol may affect them indirectly via stimulation of NPS pathway.
Chronic administration of haloperidol evokes several considerable side effects including prolonged sedation and tardive dyskinesia besides other motor disabilities.
Recent data suggested the role of NPS in locomotion and related these actions with dopaminergic signaling (44) . It was shown that intracerebroventricular infusion of NPS to the striatum and substantia nigra increase the locomotor activity in rats. This effect is Ethical standards
